Trial Phase
Trial Status
Paid Participation
Clear All
40 Pulmonary Fibrosis Trials
Power is an online platform that helps thousands of Pulmonary Fibrosis patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
BMS-986278 for Idiopathic Pulmonary Fibrosis
Columbus, OhioKey Eligibility Criteria
BI 1015550 for Pulmonary Fibrosis
Columbus, OhioKey Eligibility Criteria
Inhaled Treprostinil for Pulmonary Fibrosis
Columbus, OhioInhaled Treprostinil for Pulmonary Fibrosis
Columbus, OhioKey Eligibility Criteria
BMS-986278 for Pulmonary Fibrosis
Columbus, OhioKey Eligibility Criteria
Antibiotics for Cystic Fibrosis Pulmonary Exacerbations
Columbus, OhioKey Eligibility Criteria
Gene Therapy (4D-710) for Cystic Fibrosis
Columbus, OhioKey Eligibility Criteria
RSP-1502 Inhalation for Cystic Fibrosis
Columbus, OhioKey Eligibility Criteria
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Columbus, OhioN-acetyl Cysteine for Idiopathic Pulmonary Fibrosis
Columbus, OhioLYT-100 for Idiopathic Pulmonary Fibrosis
Cincinnati, OhioEfzofitimod for Sarcoidosis
Cincinnati, OhioAP01 for Pulmonary Fibrosis
Cincinnati, OhioKey Eligibility Criteria
Bexotegrast for Idiopathic Pulmonary Fibrosis
Cincinnati, OhioAntibiotic Treatments for Cystic Fibrosis
Cincinnati, OhioKey Eligibility Criteria
Buloxibutid for Pulmonary Fibrosis
Cleveland, OhioKey Eligibility Criteria
Vixarelimab for Pulmonary Fibrosis
Muncie, IndianaKey Eligibility Criteria
HZN-825 for Idiopathic Pulmonary Fibrosis
Cleveland, OhioKey Eligibility Criteria
Lung and Bone Marrow Transplant for Pulmonary Fibrosis
Pittsburgh, PennsylvaniaKey Eligibility Criteria
Smartphone Evaluation for Airway Diseases
Pittsburgh, PennsylvaniaKey Eligibility Criteria
DWN12088 for Idiopathic Pulmonary Fibrosis
Pittsburgh, PennsylvaniaKey Eligibility Criteria
ENV-101 for Pulmonary Fibrosis
Ann Arbor, MichiganKey Eligibility Criteria
GSK3915393 for Pulmonary Fibrosis
Ann Arbor, MichiganKey Eligibility Criteria
EGCG for Pulmonary Fibrosis
Ann Arbor, MichiganKey Eligibility Criteria
EGCG for Pulmonary Fibrosis
Ann Arbor, MichiganKey Eligibility Criteria
Ifetroban for Pulmonary Fibrosis
Indianapolis, IndianaKey Eligibility Criteria
BI 1839100 for Pulmonary Fibrosis
Warren, MichiganKey Eligibility Criteria
BI 1819479 for Pulmonary Fibrosis
Warren, MichiganKey Eligibility Criteria
Sirolimus for Post-COVID Fibrosis Prevention
Chicago, IllinoisKey Eligibility Criteria
Frequently Asked Questions
How much do Pulmonary Fibrosis clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Pulmonary Fibrosis clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Pulmonary Fibrosis trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Pulmonary Fibrosis is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Pulmonary Fibrosis medical study ?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Pulmonary Fibrosis clinical trials ?
Most recently, we added Hyperpolarized Xenon-129 MRI for Idiopathic Pulmonary Fibrosis, Buloxibutid for Pulmonary Fibrosis and Antibiotic Treatments for Cystic Fibrosis to the Power online platform.